esearch article
Full text access
An endoplasmic reticulum-targeted near-infrared fluorogenic probe reveals butyrylcholinesterase upregulation and baicalein-mediated neuroprotection in cerebral ischemia-reperfusion injury
,
,
,
,
,
,
,
,
- a
- NHC Key Laboratory of Tropical Disease Control, Engineering Research Center for Hainan Bio-Smart Materials and Bio-Medical Devices, Key Laboratory of Hainan Functional Materials and Molecular Imaging, School of Life Sciences and Medical Technology, Hainan Medical University, Haikou, Hainan, 571199, China
- b
- Key Laboratory of Emergency and Trauma, Ministry of Education, Key Laboratory of Haikou Trauma, Key Laboratory of Hainan Trauma and Disaster Rescue, Department of Pharmacy & Engineering Research Center of Tropical Medicine Innovation and Transformation, The First Affiliated Hospital, Hainan Medical University, Haikou, Hainan, 571199, China
- c
- Department of Pharmacy, The First People's Hospital of Foshan (The Affiliated Foshan Hospital of Southern University of Science and Technology), School of Medicine, Southern University of Science and Technology, Guangdong, 528000, China
Highlights
•DCIO-B enables ER-targeted near-infrared imaging of endogenous BChE activity.
•BChE upregulation was first visualized in OGD/R cells and MCAO/R mice
•DCIO-B tracked BChE changes associated with baicalein neuroprotection.
Abstract
The cholinergic anti-inflammatory pathway is an important neuroimmune regulatory axis that endogenously counteracts cerebral ischemia-reperfusion injury (CIRI). As a key hydrolase in the cholinergic system, there remains a lack of direct imaging evidence regarding changes in BChE during this pathological process. To address this challenge, we developed DCIO-B, an endoplasmic reticulum (ER)-targeted near-infrared fluorogenic (NIRF) probe, to track changes in BChE activity during CIRI at both the cellular and in vivo levels. Upon catalysis by BChE, DCIO-B produced a detectable fluorescence response at 660 nm with a detection limit of 0.041 U/mL and maintained a stable response across a wide pH range. In PC12 cells, iso-OMPA markedly blocked fluorescence, while hydrocortisone and forskolin induced opposite fluorescence changes, demonstrating that DCIO-B could visualize the bidirectional regulation of endogenous BChE. Following OGD/R treatment, intracellular BChE protein expression increased, and enhanced DCIO-B fluorescence was observed. In MCAO/R mice, brain fluorescence rapidly increased following tail-vein injection of DCIO-B, indicating elevated BChE activity. Treatment with baicalein decreased brain fluorescence signals, reduced the extent of cerebral infarction, and improved neuronal histological damage. The results verified that BChE activity increased in CIRI and provided a reliable NIRF probe, DCIO-B, for the diagnosis and intervention of CIRI.
